SecBot SecBot
8-K ·Filed Mar 12, 2026

CADL

Candel Therapeutics, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed7mo ago SEC0001193125-26-103126
8-K Item 2.02: Earnings release
Actionable Insight • Neutral

Monitor for the release of the full 8-K filing, particularly the earnings press release (Exhibit 99.1), to assess revenue, EPS, and guidance. The recent insider buying may indicate positive sentiment ahead of disclosed results.

DirectionNeutral
Confidencelow
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
CADL ▲ +70.88% at T+60d
NEUTRAL call +70.88% · α vs SPY +60.19% · entry $4.98 → $8.51
Entry = T+0 close
Mar 12, 2026
via day close
T+1d
-6.22%
call -6.22% · α -5.63%
$4.67
settled 8mo ago
T+5d
-1.41%
call -1.41% · α -0.43%
$4.91
settled 7mo ago
T+20d
-3.01%
call -3.01% · α -4.99%
$4.83
settled 7mo ago
T+60d
+70.88%
call +70.88% · α +60.19%
$8.51
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Analysis based on filing metadata only — document content was unavailable. The 8-K indicates a material event related to results of operations (Item 2.02) and financial exhibits (Item 9.01), but no financial details or forward guidance can be confirmed without the full filing. Recent insider buying of $3.0M suggests potential confidence in near-term developments.

Key Facts

  • Filing is an 8-K with Items 2.02 (Results of Operations) and 9.01 (Financial Statements and Exhibits)
  • No actual financial data or press release content available for analysis
  • Recent insider buying activity: $3.0M in the last 30 days

Financial Impact

Not specified

Risk Factors

  • Filing could contain material negative information (e.g., revenue decline, loss, lowered guidance) that is currently unknown
  • Lack of access to exhibit documents increases information asymmetry risk

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

Report based on filing metadata.

21 reports for CADL
Performance horizon
100% Hit rate @ T+60 4 of 4 directional calls Went positive at some point 6 of 6 best @ T+60▲ +67.70%Mar 17, 2026
Filters
Rows
Reports for CADL — sortable, filterable
TypeNow
Oct 1, 2026
25d ago
Press Release
BULLISH ★ 7/10
$10.16awaiting T+60—$8.03 (−20.96%)
Sep 30, 2026
26d ago
Press Release
NEUTRAL ★ 4/10
$10.44awaiting T+60—$8.03 (−23.08%)
Sep 10, 2026
6w ago
8-K
NEUTRAL ★ 4/10
$11.33awaiting T+60—$8.03 (−29.13%)
Sep 9, 2026
6w ago
8-K
NEUTRAL ★ 4/10
$11.33awaiting T+60—$8.03 (−29.13%)
Aug 15, 2026
10w ago
Institutional Cluster
NEUTRAL ★ 4/10
$12.16awaiting T+60—$8.03 (−33.96%)
Aug 13, 2026
10w ago
8-K
NEUTRAL ★ 4/10
$11.80awaiting T+60—$8.03 (−31.95%)
Aug 13, 2026
10w ago
Press Release
BULLISH ★ 7/10
$11.80awaiting T+60—$8.03 (−31.95%)
Aug 3, 2026
12w ago
Press Release
NEUTRAL ★ 2/10
$10.07awaiting T+60—$8.03 (−20.26%)
Jul 1, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$9.83 $11.19▲ +13.84%▲ +11.04%$8.03 (−18.31%)
Jul 1, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$9.83 $11.19▲ +13.84%▲ +11.04%$8.03 (−18.31%)
Showing 10 of 21

US Market Status

Market Closed — Opens Wed (12h 39m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 12, 2026